Neurogene
Rebecca Cram has a diverse work experience in various industries. In 2016, they worked as a Medical Intern for MSPCA-Angell. From 2012 to 2016, they were a Crew Member at Dunking Donut. In 2015, they worked as an Undergraduate Research Assistant at the University of New England, where they conducted experiments, analyzed data, and maintained laboratory facilities. At Louisiana Tech University, they served as a Graduate Teaching Assistant and a Graduate Research Assistant from 2018 to 2020. In these roles, they assisted with ongoing research projects and contributed to scientific manuscripts. In 2020, Rebecca worked as a Door Dasher for DoorDash. From 2021 to 2021, they were a Quality Control Analyst II at Lonza. Currently, they are employed as a Bioanalytical Development Scientist at Neurogene Inc.
Rebecca Cram completed their Bachelor of Science degree in Animal Behavior and Psychology at the University of New England from 2015 to 2017. Subsequently, they pursued their Master's degree in Biology/Biological Sciences at Louisiana Tech University from 2018 to 2020.
This person is not in any offices
Neurogene
Neurogene was founded to bring life-changing medicines to patients and families affected by rare neurological disorders. We partner with leading academic researchers, patient advocacy organizations and caregivers to bring to patients therapies that address the underlying genetic cause of a broad spectrum of neurological diseases where no effective treatment options exist today. Our lead programs use AAV-based gene therapy technology to deliver a normal gene to patients with a dysfunctional gene. Neurogene is also investing in novel technology to develop treatments for diseases not well served by gene therapy.